XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue    
Revenue $ 12,581 $ 2,113
Operating expenses    
Research and development 18,462 13,782
General and administrative 4,892 3,878
Change in fair value of contingent consideration 201 129
Total operating expenses 23,555 17,789
Loss from operations (10,974) (15,676)
Interest income 159 39
Interest expense (506) (772)
Foreign exchange (loss) gain 0 28
Total other loss (347) (705)
Loss before income taxes (11,321) (16,381)
Net loss (15,765) (16,381)
Items applicable to preferred shares:    
Dividend accretion of convertible preferred shares. 0 (3,212)
Net loss attributable to common shares $ (15,765) $ (19,593)
Loss per share    
Basic (in USD per share) $ (0.11) $ (0.21)
Diluted (in USD per share) $ (0.11) $ (0.21)
Weighted average number of common shares    
Basic (in shares) 148,428,326 93,434,378
Diluted (in shares) 148,428,326 93,434,378
Comprehensive (loss) income    
Unrealized (loss) gain on available-for-sale securities $ (1,071) $ 3
Comprehensive loss (16,836) (16,378)
Income Tax Expense (Benefit) 4,444 0
Collaborations and licenses    
Revenue    
Revenue 11,218 1,154
Non-cash royalty revenue    
Revenue    
Revenue $ 1,363 $ 959